ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2850

Human Toll-like Receptor 8 Adversely Affects Placental Development and Pregnancy Outcomes in a Mouse Model of Systemic Lupus Erythematosus

Naomi I. Maria1, Shani Martinez1 and Anne Davidson2, 1Center for Autoimmunnity, Musculoskeletal & Hematopoietic Diseases, Feinstein Institute for Medical Research, Manhasset, NY, 2Center for Autoimmunity, Musculoskeletal & Hematopoietic Diseases, Feinstein Institute for Medical Research, Manhasset, NY

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: neutrophils, placenta, pregnancy, systemic lupus erythematosus (SLE) and toll-like receptors

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: 5T105 ACR Abstract: Innate Immunity (2850–2855)

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Systemic Lupus Erythematosus (SLE) predominantly affects women of childbearing age and is associated with adverse pregnancy outcomes including pre-eclampsia, intrauterine fetal growth restriction (IUGR), placental abnormalities and maternal and fetal mortality, particularly during active disease or in the presence of antiphospholipid antibodies (aPL). Pro-inflammatory factors rather than thrombosis are now thought to be the main contributor to placental and fetal damage in women with APS. Pathogenic mechanisms that damage the fetal-maternal unit and cause abnormal placental development, however, remain poorly understood. The endosomal RNA sensor Toll-like receptor 8 (TLR8) that is predominantly expressed in macrophages and neutrophils was recently hypothesized to play a role in antiphospholipid syndrome (APS) and aPL antibody-induced placental and fetal damage. The role of TLR8 in systemic autoimmunity remains elusive as TLR8 function differs from mouse to man with respect to recognition of RNA. We are currently studying the functional consequences of one or two copies of human (huTLR8) in murine SLE, and hypothesize that the presence of huTLR8 and aPLs will adversely affect pregnancy outcomes in SLE.

Methods: Sle1 mice expressing huTLR8 as a BAC transgene (huTR8tg) were generated and followed clinically. HuTLR8 DNA copy number and mRNA expression was confirmed by qDigital and qRT-PCR respectively. Pregnancies were closely followed and terminal C-sections were performed in pregnant females with dead pups or exhibiting signs of dystocia or prolonged end-stage pregnancy. Pup and placental weight was assessed. Placental tissues were histologically characterized by H&E and immunohistochemical staining for neutrophil GR1-Ly6 and the granular protein Myeloperoxidase (MPO) to distinguish intact from netting neutrophils. Additionally, placental tissue was stored for further mRNA and microRNA analysis. Auto-antibody status in serum from pregnant females was assessed.

Results: Female huTLR8tg Sle1 mice manifested splenomegaly [mean 0.323g, n=16] compared to their non-huTLR8 counterparts [mean 0.123g, n=18] (p=0.0013) and developed anti-cardiolipin antibodies at a younger age than their wild type controls. We observed 26/55=47% loss of litters due to fetal resorption/dystocia resulting in fetal and maternal death, compared with 0% in n=20 Sle1 controls. Pup weights were significantly lower (p<0.0001) for stuck/dead pups [median 1.212g, n=31] compared to normal pups [median 1.649g, n=55]. Abnormal placental morphology was observed, with dense tissue structure, defective vasculature and increased GR1-Ly6 neutrophil infiltration. An increase in netting neutrophils was identified by MPO as decondensed non-intact nuclei.

Conclusion: We observed 47% loss of litters in huTLR8tg Sle1 pregnancies due to fetal resorption/dystocia resulting in both fetal and maternal death. This was due to placental developmental abnormalities, including vascular remodeling and inflammation in the presence of aPLs. Here we identify a potential new model to study adverse pregnancy complications in SLE and APS and further define the mechanistic role of TLR8 in promoting pregnancy loss.


Disclosure: N. I. Maria, None; S. Martinez, None; A. Davidson, None.

To cite this abstract in AMA style:

Maria NI, Martinez S, Davidson A. Human Toll-like Receptor 8 Adversely Affects Placental Development and Pregnancy Outcomes in a Mouse Model of Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/human-toll-like-receptor-8-adversely-affects-placental-development-and-pregnancy-outcomes-in-a-mouse-model-of-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/human-toll-like-receptor-8-adversely-affects-placental-development-and-pregnancy-outcomes-in-a-mouse-model-of-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology